However, important information regarding in-depth mechanism by which PD-1 signaling is involved in cancer mediated immune-suppression, with the aim of identifying new targets for drug action and exploitation of the target to design and develop safe and effective medication, is warranted. Here, PDCD1 is linked to cancer.